Moderna, Inc.
MRNA
$26.26
-$0.46-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 43.75% | 24.46% | 35.83% | -586.08% | -224.75% |
| Total Depreciation and Amortization | -66.84% | -69.57% | -33.67% | 45.45% | 66.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.76% | 55.94% | -151.25% | 294.74% | 243.46% |
| Change in Net Operating Assets | -118.44% | -111.32% | -214.04% | 188.80% | 151.02% |
| Cash from Operations | -5.90% | 3.66% | -54.33% | -1,334.07% | -390.23% |
| Capital Expenditure | -23.04% | -48.66% | -29.36% | -39.77% | -107.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.86% | -39.98% | -38.10% | -38.28% | 153.93% |
| Cash from Investing | 10.72% | -53.66% | -47.24% | -47.61% | 205.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 96.34% | 96.30% | 40.10% | -0.53% | -38.20% |
| Issuance of Common Stock | 1.89% | 40.43% | 22.81% | 13.11% | -14.52% |
| Repurchase of Common Stock | -- | -- | 100.00% | 100.00% | 80.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 105.60% | 104.07% | 97.07% | 95.57% | 75.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.99% | -245.67% | -1,384.09% | -243.22% | 13.07% |